Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — PDEX

Balance Sheet

(in millions USD)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	11.76	8.19	6.63	5.27	0.03	0.42	0.03	0.07	3.08	2.63	3.22	1.29	1.90	2.94	2.09	0.38	2.80	0.85	4.76	5.25
Short-term Investments	1.23	1.15	0.99	0.86	10.04	6.74	5.42	4.67	4.74	4.22	1.00	0.76	1.01	1.13	1.15	1.13	0.81	0.76	1.13	1.24
Accounts Receivable	17.51	21.21	19.47	17.88	18.23	16.43	15.86	18.47	13.46	13.89	12.52	13.17	11.03	9.95	10.57	12.20	11.05	15.38	8.68	8.85
Inventory	21.90	21.46	22.36	21.71	21.56	22.21	23.43	19.61	16.60	15.27	14.24	15.03	16.26	16.17	15.15	15.14	15.66	12.68	11.87	9.29
Total Current Assets	53.95	53.25	53.71	49.19	50.72	47.30	49.94	44.30	38.50	36.61	35.96	36.60	31.42	30.98	31.15	31.39	31.84	31.17	28.10	26.09
Property, Plant & Equipment	5.36	5.37	--	--	--	5.15	6.09	6.11	5.18	5.02	5.19	5.33	4.95	5.08	5.16	5.20	4.85	4.83	--	--
Goodwill	6.53	6.53	6.53	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Intangible Assets	0.67	0.69	0.71	0.01	0.02	0.03	0.03	0.04	0.05	0.05	0.06	0.07	0.08	0.08	0.09	0.10	0.11	0.12	0.16	0.16
Total Non-current Assets*	22.64	21.26	21.27	13.07	13.58	13.90	14.33	16.07	15.81	15.87	14.59	14.83	18.16	20.84	15.83	16.19	16.13	16.16	15.79	16.03
Total Assets	76.59	74.51	74.98	62.26	64.30	61.19	64.27	60.37	54.31	52.48	50.55	51.43	49.59	51.82	46.98	47.58	47.97	47.33	43.88	42.11
Accounts Payable	5.32	4.26	5.25	4.11	3.97	4.61	5.96	5.69	4.44	4.51	3.44	2.91	2.74	2.26	3.07	3.36	3.55	3.76	3.53	2.32
Total Current Liabilities	12.88	12.98	14.64	12.20	13.60	14.63	18.32	17.14	11.29	12.89	10.42	9.99	8.28	9.68	10.14	11.67	11.67	11.35	7.72	5.97
Long-term Debt	--	17.51	--	--	--	15.43	--	--	--	11.96	--	--	--	12.80	--	--	--	13.59	10.58	10.90
Total Non-current Liabilities	14.36	13.89	15.14	8.42	9.18	9.93	10.67	11.41	12.15	8.72	9.19	9.65	10.11	10.56	10.99	11.44	11.88	12.30	13.89	14.14
Total Liabilities	27.24	26.88	29.78	20.63	22.79	24.56	28.99	28.55	23.43	21.61	19.61	19.64	18.39	20.23	21.14	23.11	23.55	23.66	21.61	20.11
Retained Earnings	49.35	47.63	45.20	41.63	40.61	35.93	34.73	31.46	29.42	26.95	25.36	24.71	24.21	24.82	19.25	17.94	17.06	15.99	14.58	14.12
Total Stockholder Equity	49.35	47.63	45.20	41.63	41.51	36.63	35.28	31.82	30.88	30.87	30.94	31.79	31.20	31.59	25.84	24.47	24.42	23.67	22.27	22.01

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Total Revenue	20.56	20.41	19.95	18.66	18.53	17.49	17.41	16.79	14.89	15.03	14.29	12.59	11.94	10.64	13.08	11.28	11.09	12.62	9.27	10.17
Cost of Revenue	13.70	13.31	13.82	12.92	13.16	14.00	11.62	11.72	9.74	10.94	10.29	9.79	8.28	7.28	9.27	8.66	8.13	9.17	6.41	6.77
Gross Profit	6.86	7.09	6.13	5.74	5.37	3.49	5.80	5.07	5.15	4.09	4.00	2.80	3.66	3.36	3.81	2.62	2.96	3.44	2.86	3.40
Research & Development	1.21	1.02	0.83	0.73	0.77	0.90	0.95	0.94	0.84	0.84	0.76	0.79	0.81	0.70	0.71	0.47	0.93	0.73	0.66	0.62
Selling, General & Admin	2.13	2.55	2.21	1.75	1.42	1.11	1.10	1.39	1.25	0.87	1.01	1.20	1.00	1.04	1.01	0.95	1.02	1.50	1.15	1.17
Total Operating Expenses	3.34	3.56	3.04	2.48	2.26	2.15	2.16	2.38	2.14	1.74	1.79	2.03	1.83	1.75	1.75	1.49	2.01	2.26	1.84	1.80
Operating Income	3.52	3.53	3.09	3.26	3.11	1.34	3.64	2.69	3.01	2.35	2.21	0.78	1.83	1.61	2.07	1.14	0.95	1.18	1.02	1.60
Interest Expense	--	--	0.20	0.14	0.20	--	0.25	0.20	0.15	--	0.14	0.14	0.13	0.14	0.13	0.13	0.13	0.12	0.11	0.12
Pretax Income	3.38	3.53	5.34	2.93	6.22	1.60	4.55	2.59	3.32	1.93	0.91	0.62	(0.83)	5.19	1.77	1.17	1.29	1.49	--	--
Tax Provision	0.33	0.67	1.40	0.74	1.54	0.40	1.28	0.55	0.85	0.34	0.26	0.12	(0.21)	1.39	0.46	0.30	0.22	0.09	0.17	0.28
Net Income	3.05	2.86	3.94	2.19	4.68	1.20	3.28	2.04	2.47	1.59	0.66	0.50	(0.61)	3.81	1.31	0.88	1.08	1.40	0.46	0.93
Basic EPS	0.95	--	1.23	0.67	1.43	0.34	1.00	0.63	0.76	0.45	0.19	0.14	(0.17)	1.06	0.37	0.25	0.30	0.39	0.13	0.25
Diluted EPS	0.92	--	1.20	0.66	1.40	0.33	0.98	0.61	0.75	0.44	0.19	0.14	(0.17)	1.06	0.36	0.24	0.29	0.37	0.12	0.25

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Cash Flow	6.49	(0.27)	1.63	3.57	2.31	(0.17)	0.75	(4.15)	1.89	1.02	4.08	0.71	0.39	0.63	2.34	(0.39)	2.89	(5.28)	0.21	1.52
Capital Expenditures	0.35	0.20	0.11	0.07	0.10	--	0.18	0.54	0.43	--	0.12	0.63	0.13	--	0.14	0.51	0.18	--	0.20	1.07
Free Cash Flow*	6.14	(0.48)	1.52	3.50	2.21	--	0.57	(4.69)	1.46	--	3.96	0.08	0.27	--	2.20	(0.90)	2.71	--	0.02	0.45
Investing Cash Flow	(0.35)	0.20	(5.05)	8.87	(0.10)	(0.99)	1.73	(0.54)	(0.43)	(0.11)	(0.12)	(1.88)	(0.13)	(0.15)	(0.13)	(0.51)	(0.09)	0.40	(0.21)	(0.56)
Financing Cash Flow	(2.58)	(1.73)	5.46	(5.00)	(2.12)	(2.89)	1.93	1.68	(1.01)	(1.50)	(2.03)	0.56	(1.30)	0.37	(0.50)	(1.51)	(0.85)	0.97	(0.50)	(0.89)

← Scroll for more columns →

* Derived from reported values